HY reports a robust first quarter with significant gains in revenue and operating profit, alongside strategic progress in product development.
Explore key financial outcomes and strategic milestones as Mind Medicine navigates increased expenses and promising clinical advancements.
Explore key financial outcomes, strategic expansions, and future projections from The RMR Group's latest earnings call.